Stay updated on SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial

Sign up to get notified when there's something new on the SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated from version 2.9.7 to 2.10.0, indicating a new release with potential enhancements or features.
    Difference
    0.2%
    Check dated 2024-07-23T14:01:26.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T06:14:11.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T13:32:53.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T09:54:45.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T08:40:01.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Show more Revision: v2.9.0' has been updated to 'Show less Drug Information available for: Pembrolizumab FDA Drug and Device Resources Show less'. This change indicates a modification in the displayed content regarding drug information availability for Pembrolizumab.
    Difference
    33%
    Check dated 2024-06-25T08:20:33.000Z thumbnail image

Stay in the know with updates to SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT plus Immunotherapy in Early NSCLC Pre-Surgery Clinical Trial page.